| BID | 5.99 | ASK | 6.05 | ||
| Open | 6.22 | Previous Close | 6.30 | ||
| Pre-Market | 6.26 | After-Market | - | ||
| -0.04 -0.63% | - - |
| Target Price | 18.67 | Analyst Rating | Strong Buy 1.00 | |
| Potential % | 210.65 | Finscreener Ranking | ★+ 45.14 | |
| Insiders Trans % 3/6/12 mo. | -100/-100/41 | Value Ranking | ★ 42.28 | |
| Insiders Value % 3/6/12 mo. | -100/-100/151 | Growth Ranking | ★★ 44.38 | |
| Insiders Shares Cnt. % 3/6/12 mo. | -100/-100/77 | Income Ranking | — - | |
| Market Cap | 44.99M | Earnings Rating | Strong Buy | |
| Price Range Ratio 52W % | 9.35 | Earnings Date | 13th May 2021 |
Today's Price Range 5.966.40 | 52W Range 4.9516.39 | 5 Year PE Ratio Range -3.40-1.90 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -11.27% | ||
| 1 Month | -26.66% | ||
| 3 Months | -42.73% | ||
| 6 Months | -18.18% | ||
| 1 Year | 9.27% | ||
| 3 Years | -89.21% | ||
| 5 Years | -94.89% | ||
| 10 Years | -95.39% |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | -222.39 | |||
ROE last 12 Months | -223.11 | |||
ROA (5Y Avg) | -116.17 | |||
ROA last 12 Months | -141.06 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -190.33 | |||
Return on invested Capital Q | -65.70 | |||
Return on invested Capital Y | -42.67 | |||
Assets Turnover | 0.30 | |||
Receivables Turnover | 2.30 |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -2.30 | ||||
| 9.65 | ||||
| 20.98 | ||||
| - | ||||
| -4.80 | ||||
| -2.68 | ||||
| 11.38 | ||||
| 0.77 | ||||
| 51.91M | ||||
| Forward PE | 11.26 | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.80 | ||||
| 2.20 | ||||
| 0.03 | ||||
| 0.15 | ||||
| -158.50 | ||||
| Leverage Ratio | 1.80 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 74.90 | ||||
| -455.50 | ||||
| -445.00 | ||||
| -339.10 | ||||
| - |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 2.36M | ||||
| 0.32 | ||||
| -20.33 | ||||
| -16.57 |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q01 2021 | -0.55 | -0.62 | -12.73 |
| Q04 2020 | -0.59 | -0.82 | -38.98 |
| Q03 2020 | -0.62 | -0.72 | -16.13 |
| Q02 2020 | - | -0.79 | - |
| Q01 2020 | - | -1.12 | - |
| Q04 2019 | - | -1.44 | - |
| Q03 2019 | - | -1.60 | - |
| Q02 2019 | - | -3.20 | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| 3/2021 QR | -0.17 | 22.73 | Positive |
| 6/2021 QR | 0.03 | -57.14 | Negative |
| 9/2021 FY | -0.40 | -42.86 | Negative |
| 9/2022 FY | 0.63 | - | - |
| Next Report Date | 13th May 2021 |
| Estimated EPS Next Report | -0.17 |
| Estimates Count | 2 |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 171.02K |
| Shares Outstanding | 7.47M |
| Trades Count | 1.24K |
| Dollar Volume | 12.33M |
| Avg. Volume | 1.39M |
| Avg. Weekly Volume | 197.74K |
| Avg. Monthly Volume | 764.12K |
| Avg. Quarterly Volume | 825.81K |
Applied DNA Sciences Inc. (NASDAQ: APDN) stock closed at 6.3 per share at the end of the most recent trading day (a -3.37% change compared to the prior day closing price) with a volume of 123.49K shares and market capitalization of 44.99M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 61 people. Applied DNA Sciences Inc. CEO is James A. Hayward.
The one-year performance of Applied DNA Sciences Inc. stock is 9.27%, while year-to-date (YTD) performance is 23.53%. APDN stock has a five-year performance of -94.89%. Its 52-week range is between 4.95 and 16.39, which gives APDN stock a 52-week price range ratio of 9.35%
Applied DNA Sciences Inc. currently has a PE ratio of -2.30, a price-to-book (PB) ratio of 9.65, a price-to-sale (PS) ratio of 20.98, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -141.06%, a ROC of -190.33% and a ROE of -223.11%. The company’s profit margin is -%, its EBITDA margin is -445.00%, and its revenue ttm is $2.36 Million , which makes it $0.32 revenue per share.
Of the last four earnings reports from Applied DNA Sciences Inc., there were 0 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.17 for the next earnings report. Applied DNA Sciences Inc.’s next earnings report date is 13th May 2021.
The consensus rating of Wall Street analysts for Applied DNA Sciences Inc. is Strong Buy (1), with a target price of $18.67, which is +210.65% compared to the current price. The earnings rating for Applied DNA Sciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Applied DNA Sciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Applied DNA Sciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 18.78, ATR14 : 0.94, CCI20 : -135.17, Chaikin Money Flow : -0.56, MACD : -0.92, Money Flow Index : 71.26, ROC : -11.27, RSI : 39.80, STOCH (14,3) : 2.14, STOCH RSI : 0.25, UO : 29.79, Williams %R : -97.86), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Applied DNA Sciences Inc. in the last 12-months were: Scott L. Anchin (Option Excercise at a value of $56 240), Scott L. Anchin (Sold 13 049 shares of value $110 042 ), William W. Montgomery (Buy at a value of $-541 616)
Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a provider of DNA-based supply chain, anti-counterfeiting, and anti-theft technology. The company provides its products and services under the brand of SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. It serves clients in various industries including government/military, security and asset marking, industrial parts, pharmaceuticals, textiles and apparel, and printing and packaging. The company has operational footprints across the United States, Europe, Asia, and others.
CEO: James A. Hayward
Telephone: +1 631 840-8800
Address: 50 Health Sciences Drive, Stony Brook 11790, NY, US
Number of employees: 61
